Asupan makan, status gizi, dan kualitas hidup pasien kanker payudara di RSUP DR Sardjito Yogyakarta

Background: Breast cancer is the fifth leading cause of death due to all the type of cancer and the second leading cause of death in developing country after lung cancer. The global incidents of this disease were 43%. The cancer cells have an ability to disturb the nutrients absorbtion in the body and give an effect of decreasing nutritional status, physical performance and quality of life. Objective: To show the relationship between nutrient intake, nutritional status and quality of life, breast cancer patients with radiotherapy at RSUP Dr Sardjito Yogyakarta. Method: This study was an observational study with cross sectional design. Total subject of this study were 85 respondents. Intake of energy, protein, fat and carbohydrate were measured using 1x24 hours food recall. Nutritional status were measured using patient-generated subjective global assessment (PG-SGA) questionnaire. Then the quality of life were measured using European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30) questionnaire. Results: There were significant difference in the average intake of energy (p=0.013), protein (p=0.043) and fat (p=0.016) between severe malnourished, moderate malnourished and wellnourished patients, whereas the average intake of carbohydrate was not significant (p=0.070). The lower nutrition intake, the lower nutritional status. There was also significant difference in fat intake (p=0.035) and nutritional status based on PG-SGA (p=0.002) between patients with poor and good quality of life. Patients with poor quality of life had lower nutrition intake and nutritional status. Conclusion: Nutrient intake gave an effect to nutritional status and quality of life in breast cancer patient with radiotherapy

KOMPARASI DOSIS RADIASI YANG DITERIMA OPERATOR PERCUTANEOUS CORONARY INTERVENTION DENGAN NILAI BATAS DOSIS MENURUT PENETAPAN BADAN PENGAWAS TENAGA NUKLIR

Introduction. Percutaneous coronary intervention (PCI) is the mostly done therapeutic interventional procedure in RSUP Dr. Sardjito. Monitoring the radiation dose received by operators and keep that dose within the safe limit are very important to avoid the possible radiation effects. Aims. The aims of this study were to compare the radiation dose of each PCI and cumulative dose received by operator to the radiation exposure limit (nilai batas dosis/NBD) and to compare the radiation dose at gonad height to chest height. Subject and Method. This was a comparative analytic observational study. Subjects were the operators of PCI procedures in Cath-lab Room 1 and 2 RSUP Dr. Sardjito in February-April 2014 who met the inclusion and exclusion criteria. The sampling method was consecutive sampling. The association between variables was analyzed comparatively, using numeric-comparative hypothesis

PENGARUH BEBAN MAKANAN BERLEMAK DAN MAKANAN TANPA LEMAK TERHADAP KECEPATAN ALIRAN VENA PORTA PADA PEMERIKSAAN SONOGRAFI COLOR DOPPLER

Color doppler sonography represent important non-invasive modality to diagnose abnormality at the liver. Abnormality at the liver relied on some normally parameter portal venous and hepatica artery from color doppler sonography. With color doppler sonography can be known the decrease of portal venous velocity and the increase of portal venous diameter that representing two characteristics of portal hypertension Portal venous velocity at normal people is 15-20 cm/sec at the basal state. Portal venous velocity will increase at or in post prandial situation. Drinking some water or eating some food composed protein, fat, or karbohydrat will influence situation of portal venous system indirecly. This research wanted to examine the difference of increase portal venous velocity at normal population with seen change portal venous velocity in state of fasting and 30 minute after eating fatty food or non-fatty food. The study design was a randomized controlled trial, double-blind. Samples were taken with consecutive sampling method. Study of 46 volunteer subjects in Radiology Dr Sardjito Yogyakarta in April-May 2011. Statistical analysis was used independent t-test. The result of statistical calculation with t-test get increased portal vein flow velocity in the group with provision of food without fat is higher than the group of fatty foods, with p<0.001 therefore p<0.05, the hypothesis was accepted. The conclusion that can be drawn that the increase in portal vein flow velocity was higher in the food without the fat load compared with loads of fatty foods on color doppler sonography examination

KESESUAIAN GAMBARAN KARAKTERISTIK NODUL PADA ULTRASONOGRAFI TIROID DENGAN KEJADIAN NODUL TIROID MALIGNA

Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal Thyroid nodule refers to any abnormal growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as growth of thyroid gland that manifests as a lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowe a lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowe a lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowe a lump or another rounded pathological form that palpable in the lowe a lump or another rounded pathological form that palpable in the lowe a lump or another rounded pathological form that palpable in the lowe a lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowe a lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowe a lump or another rounded pathological form that palpable in the lowe a lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowe a lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowea lump or another rounded pathological form that palpable in the lowe r anterior triangle r anterior triangle r anterior triangle r anterior triangle r anterior triangle r anterior triangle r anterior triangle r anterior triangle r anterior triangle r anterior triangle r anterior triangle r anterior triangle r anterior triangle r anterior triangle r anterior triangle r anterior triangle r anterior triangle r anterior triangle r anterior triangle r anterior triangle of the neck that of the neck that of the neck that of the neck that of the neck that of the neck that of the neck that of the neck that of the neck that of the neck that of the neck that of the neck that of the neck that of the neck that of the neck that extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging extends greater than 1.5 cm in diameter. There are varieties of imaging modality to detect thyroid nodule, omodality to detect thyroid nodule, omodality to detect thyroid nodule, o modality to detect thyroid nodule, o modality to detect thyroid nodule, omodality to detect thyroid nodule, omodality to detect thyroid nodule, omodality to detect thyroid nodule, omodality to detect thyroid nodule, omodality to detect thyroid nodule, omodality to detect thyroid nodule, o modality to detect thyroid nodule, omodality to detect thyroid nodule, omodality to detect thyroid nodule, omodality to detect thyroid nodule, omodality to detect thyroid nodule, omodality to detect thyroid nodule, omodality to detect thyroid nodule, o modality to detect thyroid nodule, omodality to detect thyroid nodule, omodality to detect thyroid nodule, omodality to detect thyroid nodule, o modality to detect thyroid nodule, omodality to detect thyroid nodule, omodality to detect thyroid nodule, o modality to detect thyroid nodule, omodality to detect thyroid nodule, omodality to detect thyroid nodule, omodality to detect thyroid nodule, omodality to detect thyroid nodule, one of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features ne of them is ultrasonography. Sonographic features of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined of thyroid nodule that need to be examined are are are are size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, size, internal component, shape, edge, echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension, and vascularization. In various echogenicity, calcification, extra capsular extension

PERBANDINGAN DOSIS RADIASI GONAD PRIA DENGAN SHIELDING 0,35 mmPb DAN SHIELDING 0,50 mmPb PADA PEMERIKSAAN HEAD MULTISLICE COMPUTED TOMOGRAPHY SCAN

Background. CT plays an increasingly important role in the field of radiodiagnostic. The usage of X-ray in CT gives primary radiation on examined organs and scattered radiation on the surrounding organs. Gonad is a radiosensitive organ, so that radiation protection is required to minimize radiation effects. There are two types of shielding (apron clothes) which are 0,35 mmPb and 0,50mmPb shielding. The purpose of this study was to compare male gonad radiation dose with 0,35 mmPb and 0,50 mmPb shielding on patients examined using Head MSCT, to discover the effectiveness of the shielding. Materials and Method. This study was conducted on patients who were examined using Head MSCT scan. Research subjects were divided into group I with 0,35 mmPb shielding and group II with 0,50 mmPb shielding. Radiodiagnostic equipment was Philips Brilliance 64 slices MSCT. TLD radiation measurement was put on the skin surface of scrotum region, then covered by shielding. Research results. There was a difference in male gonad radiation dose with 0,35 mmPb shielding (0,0126mGy � 0,0133mGy ) and 0,50 mmPb shielding (0,0045mGy ± 0,0069mGy). Statistically there was significant difference p < 0,0

KORELASI ANTARA CONCHA BULLOSA DENGAN PENEBALAN MUKOSA SINUS MAXILLARIS PADA PASIEN YANG DILAKUKAN PEMERIKSAAN MULTI SLICE COMPUTED TOMOGRAPHY SCAN POTONGAN AXIAL

Background: Concha bullosa is a common anatomic variants in the nasal cavity that may cause maxillary sinusitis. Objective: To determine the relationship between the concha bullosa and mucosal thickening of maxillary sinus in patients with axial paranasal sinus multi slice computed tomography Scan. Materials and Methods: This retrospective analytic correlative study, will be assessed the correlation between concha bullosa and mucosal thickening of maxillary sinus on 34 axial paranasal sinus multi slice computed tomography scan. Data were analyzed with the Spearman correlation test to determine the correlation between the concha bullosa and mucosal thickening of maxillary sinus. In this study, the target population is all the result of axial paranasal sinus multi slice computed tomography Scan in Dr. Sardjito Central General Hospital. While the reached population in this study is all data from axial paranasal sinus MSCT scan at Dr. Sardjito Central General Hospital on February to July 2013. Results: The study sample as many as 34 samples, men sample characteristics as much as 9 samples. Characteristics by age <30 years as much 8 samples (23.5%), aged 30-40 years were 9 samples (26.5%), aged 41-50 years were 3 samples (8.8%), age> 50 years were 14 samples (41.2%). Concha bullosa was found in the right nasal cavity as many as 21 samples (61.8%) and left nasal cavity as many as 26 samples (76.5%). Correlation concha bullosa with mucosal thickening of maxillary sinus : Right concha bullosa to right maxillary sinus p > 0.05 (p = 0.082), left concha bullosa to right maxillary sinus p > 0.05 (p = 0.112), right concha bullosa to left maxillary sinus p> 0.05 (p = 0.470) , left concha bullosa to left maxillary sinus p> 0.05 (p = 0.394) Conclusion: Concha bullosa has no significant correlation with the mucosal thickening of maxillary sinu

HUBUNGAN KADAR HEMOGLOBIN DENGAN RESPON TUMOR PADA PASIEN KANKER SERVIKS YANG MENDAPAT TERAPI RADIASI DI RSUP DR. SARDJITO

Background: Cervical cancer is the second most common cancer in women worldwide. Radiation therapy is one of the recommended therapies for cervical cancer. But its side effects can suppress bone marrow which decreases hemoglobin (Hb) levels. Hemoglobin is a protein in red blood cells that carry oxygen. During radiation therapy, tumor response depends on tissue oxygenation. Objective: To know the association between hemoglobin levels with tumor response after radiation therapy in patients with cervical cancer. Material and Methods: This study was conducted between May 2012 and February 2013 in 30 patients with cervical cancer during radiation therapy. Hemoglobin level and tumor response were taken from medical record retrospectively. Measurement of Hb levels and tumor response was performed 6 times per week for 5 weeks. Tumor response was measured from the length of tumor. This study used RECIST (Response Evaluation Criteria In Solid Tumors) to evaluate tumor response. Result: During the 5 weeks of therapy, the lowest nadir Hb level was occurred in the second week and the lowest mean Hb level was occurred in the third week. Sixty percent patients had complete response. Partial response was experienced by 40% patient. Mean hemoglobin levels (< 10.5 g/dL) associated with worsening tumor response in patients underwent radiation therapy for 5 weeks (p = 0.045). Conclusion: There was a significant association between the mean hemoglobin levels with tumor response. In this study, the low mean Hb level during radiation therapy could cause a worsening of tumor response. So, the physicians should maintain Hb level above 10.5 g/dL by iron supplementation, blood transfusion, or recombinant human erythropoietin

Proceedings Of The 7Th Biannual International Symposium On Nasopharyngeal Carcinoma 2015

A1 Hope and despair in the current treatment of nasopharyngeal cancer, IB Tan, I1 NPC international incidence and risk factors, Ellen T Chang, I2 Familial nasopharyngeal carcinoma and the use of biomarkers, Chien-Jen Chen, Wan-Lun Hsu, Yin-Chu Chien, I3 Genetic susceptibility risk factors for sporadic and familial NPC: recent findings, Allan Hildesheim, I5 Genetic and environmental risk factors for nasopharyngeal cancer in Southeast Asia, James D McKay, Valerie Gaborieau, Mohamed Arifin Bin Kaderi, Dewajani Purnomosari, Catherine Voegele, Florence LeCalvez-Kelm, Graham Byrnes, Paul Brennan, Beena Devi, I6 Characterization of the NPC methylome identifies aberrant epigenetic disruption of key signaling pathways and EBV-induced gene methylation, Li L, Zhang Y, Fan Y, Sun K, Du Z, Sun H, Chan AT, Tsao SW, Zeng YX, Tao Q, I7 Tumor exosomes and translational research in NPC, Pierre Busson, Claire Lhuillier, Olivier Morales, Dhafer Mrizak, Aurore Gelin, Nikiforos Kapetanakis, Nadira Delhem, I8 Host manipulations of the Epstein-Barr virus EBNA1 protein, Sheila Mansouri, Jennifer Cao, Anup Vaidya, and Lori Frappier, I9 Somatic genetic changes in EBV-associated nasopharyngeal carcinoma, Lo Kwok Wai, I10 Preliminary screening results for nasopharyngeal carcinoma with ELISA-based EBV antibodies in Southern China, Sui-Hong Chen, Jin-lin Du, Ming-Fang Ji, Qi-Hong Huang, Qing Liu, Su-Mei Cao, I11 EBV array platform to screen for EBV antibodies associated with NPC and other EBV-associated disorders, Denise L. Doolan, Anna Coghill, Jason Mulvenna, Carla Proietti, Lea Lekieffre, Jeffrey Bethony, and Allan Hildesheim, I12 The nasopharyngeal carcinoma awareness program in Indonesia, Renske Fles, Sagung Rai Indrasari, Camelia Herdini, Santi Martini, Atoillah Isfandiari, Achmad Rhomdoni, Marlinda Adham, Ika Mayangsari, Erik van Werkhoven, Maarten Wildeman, Bambang Hariwiyanto, Bambang Hermani, Widodo Ario Kentjono, Sofia Mubarika Haryana, Marjanka Schmidt, IB Tan, I13 Current advances and future direction in nasopharyngeal cancer management, Brian O’Sullivan, I14 Management of juvenile nasopharyngeal cancer, Enis Ozyar, I15 Global pattern of nasopharyngeal cancer: correlation of outcome with access to radiotherapy, Anne WM Lee, I16 The predictive/prognostic biomarker for nasopharyngeal carcinoma, Mu-Sheng Zeng, I17 Effect of HLA and KIR polymorphism on NPC risk, Xiaojiang Gao, Minzhong Tang, Pat Martin, Yi Zeng, Mary Carrington, I18 Exploring the Association between Potentially Neutralizing Antibodies against EBV Infection and Nasopharyngeal Carcinoma, Anna E Coghill, Wei Bu, Hanh Nguyen, Wan-Lun Hsu, Kelly J Yu, Pei-Jen Lou, Cheng-Ping Wang, Chien-Jen Chen, Allan Hildesheim, Jeffrey I Cohen, I19 Advances in MR imaging in NPC, Ann D King, O1 Epstein-Barr virus seromarkers and risk of nasopharyngeal carcinoma: the gene-environment interaction study on nasopharyngeal carcinoma in Taiwan, Yin-Chu Chien, Wan-Lun Hsu, Kelly J Yu, Tseng-Cheng Chen, Ching-Yuan Lin, Yung-An Tsou, Yi-Shing Leu, Li-Jen Laio, Yen-Liang Chang, Cheng-Ping Wang, Chun-Hun Hua, Ming-Shiang Wu, Chu-Hsing Kate Hsiao, Jehn-Chuan Lee, Ming-Hsui Tsai, Skye Hung-Chun Cheng, Pei-Jen Lou, Allan Hildesheim, Chien-Jen Chen, O2 Familial tendency and environmental co-factors of nasopharyngeal carcinoma: the gene-environment interaction study on nasopharyngeal carcinoma in Taiwan, Wan-Lun Hsu, Kelly J Yu, Yin-Chu Chien, Tseng-Cheng Chen, Ching-Yuan Lin, Yung-An Tsou, Yi-Shing Leu, Li-Jen Liao, Yen-Liang Chang, Tsung-Lin Yang, Chun-Hun Hua, Ming-ShiangWu, Chu-Hsing Kate Hsiao, Jehn-ChuanLee, Ming-Hsui Tsai, Skye Hung-Chun Cheng, Jenq-Yuh Ko, Allan Hildesheim, Chien-Jen Chen, O3 The genetic susceptibility and prognostic role of TERT-CLPTM1L and genes in DNA damage pathways in NPC, Josephine Mun Yee Ko, Wei Dai, Dora Kwong, Wai Tong Ng, Anne Lee, Roger Kai Cheong Ngan, Chun Chung Yau, Stewart Tung, Maria Li Lung, O4 Long term effects of NPC screening, Mingfang Ji, Wei Sheng, Mun Hon Ng, Weimin Cheng, Xia Yu, Biaohua Wu, Kuangrong Wei, Jun Zhan, Yi Xin Zeng, Su Mei Cao, Ningshao Xia, Yong Yuan, O5 Risk prediction of nasopharyngeal carcinoma by detecting host genetic and Epstein-Barr virus variation in saliva, Qian Cui, Miao Xu, Jin-Xin Bei, Yi-Xin Zeng, O6 Patterns of care study in Turkish nasopharyngeal cancer patients (NAZOTURK): A Turkish Radiation Oncology Association Head and Neck Cancer Working Group Study, B Şahin, A Dizman, M Esassolak, A Saran İkizler, HC Yıldırım, M Çaloğlu, B Atalar, F Akman, C Demiroz, BM Atasoy, E Canyilmaz, S Igdem, G Ugurluer, T Kütük, M Akmansoy, E Ozyar, O7 Long term outcome of intensity modulated radiotherapy in nasopharyngeal carcinoma in National Cancer Centre Singapore, Kiattisa Sommat, Fu Qiang Wang, Li-Lian Kwok, Terence Tan, Kam Weng Fong, Yoke Lim Soong, Shie Lee Cheah, Joseph Wee, O8 International phase II randomized study on the addition of docetaxel to the combination of cisplatin and 5-fluorouracil in the induction treatment for nasopharyngeal carcinoma in children and adolescents, M Casanova, E Özyar, C Patte, D Orbach, A Ferrari, VF Cristine, H Errihani, J Pan, L Zhang, S Liji, K Grzegorzewski, L Gore, A Varan, O9 Prognostic impact of metastatic status in patients with nasopharyngeal carcinoma, Susanna Hilda Hutajulu, Guntara Khuzairi, Camelia Herdini, Henry Kusumo, Mardiah Suci Hardianti, Kartika Widayati Taroeno-Hariadi, Ibnu Purwanto, Johan Kurnianda, O10 Development of small molecule inhibitors of latent Epstein-Barr virus infection for the treatment of nasopharyngeal carcinoma, Troy E. Messick, Kimberly Malecka, Lois Tolvinski, Samantha Soldan, Julianna Deakyne, Hui Song, Antonio van den Heuvel, Baiwei Gu, Joel Cassel, Mark McDonnell, Garry R Smith, Venkata Velvadapu, Haiyan Bian, Yan Zhang, Marianne Carlsen, Shuai Chen, Alastair Donald, Christian Lemmen, Allen B Reitz, Paul M Lieberman, O11 Therapeutic targeting of cancer stem-like cells using a Wnt modulator, ICG-001, enhances the treatment outcome of EBV-positive nasopharyngeal carcinoma, King Chi Chan, Lai Sheung Chan, Kwok Wai Lo, Timothy Tak Chun Yip, Roger Kai Cheong Ngan, Michael Kahn, Maria Li Lung, Nai Ki Mak, O12 Role of micro-RNA in NPC biology, Fei-Fei Liu, O13 Expansion of EBNA1- and LMP2-specific effector T lymphocytes from patients with nasopharyngeal carcinoma without enhancement of regulatory T cells, Wafa Khaali; Juliette Thariat; Laurence Fantin; Flavia Spirito; Meriem Khyatti; El Khalil Ben Driss; Sylvain Olivero; Janet Maryanski; Alain Doglio, O14 The experience of patients’ life after amifostine radiotherapy treatment (ART) for nasopharyngeal carcinoma (NPC), Mengxue Xia, Yunfei Xia, Hui Chang, Rachel Shaw, O15 Analysis of mitochondrial DNA mutation in latent membrane protein-1 positive nasopharyngeal carcinoma, Pudji Rahaju, O16 Factors influencing treatment adherence of nasopharyngeal cancer and the clinical outcomes: a hospital-based study, Mardiah Suci Hardianti, Sindhu Wisesa, Kartika Widayati Taroeno-Harijadi, Ibnu Purwanto, Bambang Hariwiyanto, Wigati Dhamiyati, Johan Kurnianda, O17 Chromosomal breaks mediated by bile acid-induced apoptosis in nasopharyngeal epithelial cells: in relation to matrix association region/scaffold attachment region, Sang-Nee Tan, Sai-Peng Sim, O18 Expression of p53 (wild type) on nasopharyngeal carcinoma stem cell that resistant to radiotherapy, Muhtarum Yusuf, Ahmad C Romdhoni, Widodo Ario K, Fedik Abdul Rantam, O19 Mathematical model of nasopharyngeal carcinoma in cellular level, Sugiyanto, Lina Aryati, Fajar Adi-Kusumo, Mardiah Suci Hardianti, O20 Differential expression of microRNA-21 on nasopharyngeal carcinoma plasma patient, SY Bintoro, R Oktriani, C. Herawati, A Surono, Sofia M. Haryana, O21 Therapeutic targeting of an oncogenic fibroblast growth factor-FGF19, which promotes proliferation and induces EMT of carcinoma cells through activating ERK and AKT signaling, L. Zhong, L. Li, B. B. Ma, A. T. Chan, Q. Tao, O22 Resist nasopharyngeal carcinoma (NPC): next generation T cells for the adoptive immunotherapy of NPC, M. Kalra, M. Ngo, S. Perna, A. Leen, N. Lapteva, C. M. Rooney, S. Gottschalk, O23 The correlation of heat shock protein 70 expressions and staging of nasopharyngeal carcinoma, Elida Mustikaningtyas, Sri Herawati, Achmad C Romdhoni, O24 Epstein-Barr virus serological profiles of nasopharyngeal carcinoma - A tribute to Werner Henle, Mingfang Ji, YaruiXu, Weimin Cheng, ShengxiangGe, Fugui Li, M. H. Ng, O25 Targeting the apoptosis pathway using combination TLR3 agonist with anti-survivin molecule (YM-155) in nasopharyngeal carcinoma, Louise SY Tan, Benjamin Wong, CM Lim, O26 The resistance mechanism of nasopharyngeal cancer stem cells to cisplatin through expression of CD44, Hsp70, p53 (wild type), Oct-4, and ß-catenin encoded-genes, Achmad C Romdhoni, Fedik A. Rantam, Widodo Ario Kentjono, P1 Prevalence of nasopharyngeal carcinoma patients at Departement of Otorhinolaringology-Head and Neck Surgery, Dr. Hasan Sadikin general hospital, Bandung, Indonesia in 2010-2014, Deasy Z Madani, Nur Akbar, Agung Dinasti Permana, P2 Case report on pediatric nasopharyngeal carcinoma at Dr. Sardjito Hospital, Yogyakarta, Camelia Herdini, Sagung Rai Indrasari, Jajah Fachiroh, Dwi Hartati, T. Baning Rahayudjati, P3 Report on loco regionally advanced nasopharyngeal cancer patients treated with induction chemotherapy followed by concurrent chemo-radiation therapy, Iswandi Darwis, Susanna Hilda Hutajulu, Bambang Hariwiyanto, Wigati Dhamiyati, Ibnu Purwanto, Kartika Widayati Taroeno-Hariadi, Johan Kurnianda, P4 Sex and age differences in the survival of patients with nasopharyngeal carcinoma, Sindhu Wisesa, Mardiah Suci Hardianti, Susanna Hilda Hutajulu, Kartika Widayati Taroeno-Harijadi, Ibnu Purwanto, Camelia Herdini, Wigati Dhamiyati, Johan Kurnianda, P5 Impact of delayed diagnosis and delayed therapy in the treatment outcome of patients with nasopharyngeal carcinoma, Khoirul Anwar, Susanna Hilda Hutajulu, Sagung Rai Indrasari, Sri Retna Dwidanarti, Ibnu Purwanto, Kartika Widayati Taroeno-Hariadi, Johan Kurnianda, P6 Anaysis of pretreatment anemia in nasopharyngeal cancer patients undergoing neoadjuvant therapy, Dominicus Wendhy Pramana, Susanna Hilda Hutajulu, Bambang Hariwiyanto, Wigati Dhamiyati, Ibnu Purwanto, Kartika Widayati Taroeno-Hariadi, Johan Kurnianda, P7 Results of treatment with neoadjuvant cisplatin-5FU in locally advanced nasopharyngeal carcinoma: a local experience, Diah Ari Safitri, Susanna Hilda Hutajulu, Camelia Herdini, Sri Retna Dwi Danarti, Ibnu Purwanto, Kartika Widayati Taroeno-Hariadi, Johan Kurnianda, P8 Geriatrics with nasopharyngeal cancer, Suryo A Taroeno, Sindhu Wisesa, Kartika Widayati Taroeno-Hariadi, Ibnu Purwanto, Bambang Hariwiyanto, Wigati Dhamiyati, Johan Kurnianda, P9 Correlation of lymphocyte to monocyte and neutrophil to lymphocyte ratio to the response of cisplatin chemoradiotheraphy in locally advance nasopharyngeal carcinoma, I. Wijaya, A. Oehadian, D. Prasetya, P10 Prediction of nasopharyngeal carcinoma risk by Epstein-Barr virus seromarkers and environmental co-factors: the gene-environment interaction study on nasopharyngeal carcinoma in Taiwan, Wan-Lun Hsu, Yin-Chu Chien, Kelly J Yu, Cheng-Ping Wang, Ching-Yuan Lin, Yung-An Tsou, Yi-Shing Leu, Li-Jen Liao, Yen-Liang Chang191,192, Jenq-Yuh Ko, Chun-Hun Hua, Ming-Shiang Wu, Chu-Hsing Kate Hsiao, Jehn-Chuan Lee, Ming-Hsui Tsai, Skye Hung-Chun Cheng, Pei-Jen Lou, Allan Hildesheim, Chien-Jen Chen, P11 Non-viral risk factors for nasopharyngeal carcinoma in West Sumatra, Indonesia, Sukri Rahman, Bestari J. Budiman, Novialdi, Rahmadona, Dewi Yuri Lestari, P12 New prototype Vidas EBV IgA quick: performance on Chinese and Moroccan populations, C. Yin, A. Foussadier, E. Blein, C. Chen, N. Bournet Ammour, M. Khiatti, S. Cao, P13 The expression of EBV-LMP1 and VEGF as predictors and plasma EBV-DNA levels as early marker of distant metastasis after therapy in nasopharyngeal cancer, Dewi Syafriyetti Soeis Marzaini, P14 Characteristics and factors influencing subjects refusal for blood samples retrieval: lesson from NPC case control study in Yogyakarta – Indonesia, Dwi Hartati, Baning Rahayujati, Camelia Herdini, Jajah Fachiroh, P15 Expression of microRNA BART-7-3p and mRNA PTEN on blood plasma of patients with nasopharyngeal carcinoma, L. Gunawan, S. Mubarika Haryana, A. Surono, C. Herawati, P16 IgA response to native early antigen (IgA-EAext) of Epstein-Barr virus (EBV) in healthy population and nasopharyngeal carcinoma (NPC) patients: the potential for diagnosis and screening tools, Michael Hartono, Jajah Fachiroh, Umi Intansari, Dewi Kartikawati Paramita, P17 IgA responses against Epstein-Barr Virus Early Antigen (EBV-EA) peptides as potential candidates of nasopharyngeal carcinoma detection marker, Akmal Akbar, Jajah Fachiroh, Dewi Kartikawati Paramita, P18 Association between smoking habit and IgA-EBV titer among healthy individuals in Yogyakarta, Indonesia, Benny Hermawan, T Baning Rahayudjati, Dewi K Paramita, Jajah Fachiroh, P19 Epstein-Barr virus IgA titer comparison of healthy non-family individuals and healthy first degree family of NPV patients, Gabriella Argy, Jajah Fachiroh, Dewi Kartikawati Paramita, Susanna Hilda Hutajulu, P20 Identification of EBV Early Antigen (EA) derived peptides for NPC diagnosis, Theodora Caroline Sihotang, Jajah Fachiroh, Umi Intansari, Dewi Kartikawati Paramita, P21 Host-pathogen study: relative expression of mRNA BRLF1 Epstein-Barr virus as a potential biomarker for tumor progressivity and polymorphisms of TCRBC and TCRGC2 host genes related to genetic susceptibility on nasopharyngeal carcinoma, Daniel Joko Wahyono, Purnomo Soeharso, Dwi Anita Suryandari, Lisnawati, Zanil Musa, Bambang Hermani, P22 In vitro efficacy of silvestrol and episilvestrol, isolated from Borneo, on nasopharyngeal carcinoma, a major cancer in Borneo, Maelinda Daker, Yeo Jiun Tzen, Norhasimah Bakar, Asma’ Saiyidatina Aishah Abdul Rahman, Munirah Ahmad, Yeo Tiong Chia, Alan Khoo Soo Beng, P23 The expression of mir-141 in patients with nasopharyngeal cancer, Widyandani Sasikirana, Tirta Wardana, Muhammad Radifar, Cita Herawati, Agus Surono, Sofia Mubarika HaryanaPubMe